Sat.Feb 22, 2025 - Fri.Feb 28, 2025

article thumbnail

Pfizer’s bet on gene therapies in haemophilia has been a bust

Pharmaceutical Technology

Pfizer has ended the global commercialisation of its haemophilia B (factor IX deficiency) gene therapy Beqvez, citing soft demand for gene therapies among haemophilia patients and physicians.

article thumbnail

Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces

MedCity News

To bridge the gap between invasive and non-invasive technologies, nanoscale materials, such as biocompatible nanoparticles, provide a promising alternative, allowing us to design materials at the scale of cellular systems and structures. The post Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces appeared first on MedCity News.

273
273
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sales Skills You Will Need As A Medical Sales Rep With Andy Olen

Evolve Your Success

From Ted Talks to the medical sales podcast! Today’s episode has a special guest, Andy Olen. In this episode, he discusses the essential sales skills required for success as a medical sales representative. Discover Andy’s expertise as he guides high-performing individuals, executive sales leaders, and professional athletes through his coaching and training organization.

article thumbnail

Kennedy’s MAHA agenda is tackling ‘conflicts of interest’ — and could take aim at FDA adcomms

PharmaVoice

Health agency job cuts and a newly-established MAHA commission leave many unanswered questions about potential reforms and impact on drug approvals.

FDA 259
article thumbnail

State of AI in Sales & Marketing 2025

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

article thumbnail

Could novel 3D printing method enhance intestinal drug delivery?

European Pharmaceutical Review

A study has demonstrated a new approach to prepare tablets for intestinal drug delivery by combining two 3D printing techniques. Using both selective laser sintering (SLS) and fused deposition modelling (FDM), the technique has potential to achieve delayed and prolonged drug release, according to the findings. Key findings from the 3D printing drug delivery study [a] laser speed of 90 mm s1 was suitable for producing [3D printed tablet] cores with relatively short disintegration time and suffici

More Trending

article thumbnail

Make a Difference in Rare Disease With Creativity, Data, and Innovation: Insights from Ann Cave

Eversana Intouch

In the ever-evolving landscape of pharmaceutical marketing, staying ahead of the curve is crucial. Ann Cave, president of full-service agencies at EVERSANA INTOUCH, shares invaluable insights in her article, “How Harnessing Creativity, Data and Innovation Can Help Make a Difference in a Rare Disease Patients Journey,” published in Med Ad News.

article thumbnail

AI deals are surging, and Recursion’s ongoing Exscientia merger points to a new world of integration

PharmaVoice

Recursion CFO Ben Taylor discusses the state of AI M&A and what companies should look for as the industry moves to new data technologies and systems.

200
200
article thumbnail

Preparing for a new era in the rare disease sector

European Pharmaceutical Review

Rare disease research has surged over the past decade. When observing literature trends over the past twenty years, the amount of rare disease literature being published each year has more than tripled ( Figure 1 ). 1 Following the current trend, there has been a significant rise in the number of documents mentioning both artificial intelligence (AI) and rare diseases.

article thumbnail

MedCity Pivot Podcast: Being Clear About Cybersecurity

MedCity News

A conversation with David Bardan, the general manager of the healthcare business at Clear, shows how the company is bringing its expertise to counter cybersecurity threats in the healthcare industry. The post MedCity Pivot Podcast: Being Clear About Cybersecurity appeared first on MedCity News.

article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

Rare but Prevalent: The Unequal Toll of Rare Diseases on Women

Eversana Intouch

In recent years, notable progress has been made to highlight the vast gap in womens health and boost awareness around it. On average, women spend 25% more of their lives in poor health compared to men, and closing this gap could add at least $1 trillion to annual global GDP by 2040. Fortunately, more publications and studies are also emerging to point out under-researched and under-diagnosed women-specific conditions (such as endometriosis and menopause) and conditions that disproportionally aff

article thumbnail

Developing High-Impact Sales Leadership in Healthcare

Healthcare Success

This week's podcast dives into successful sales leadership and is relevant to most healthcare verticals, including B2B sales in SaaS, pharmaceuticals, medical device, hospitals, etc. It also applies to high-value B2C sales, e.g., elective surgeries, orthodontics, senior care, and residential treatment centers. My guest, Chris Jennings , CEO of Chris Jennings Group , reveals the essential traits of successful healthcare sales leadership.

Sales 65
article thumbnail

Teva targets schizophrenia to build on innovative medicines growth

PharmaVoice

The company is leaning on its subcutaneous technology to deliver long-acting options that could prevent patients from cycling through drugs.

Medicine 147
article thumbnail

Eikon Raises $350M for Cancer Drug Pipeline Led by Melanoma Med in Pivotal Testing

MedCity News

Eikon Therapeutics lead drug candidate is designed to activate toll-like receptors 7 and 8, sparking an immune response that fights cancer. Beyond this TLR7/8 agonist, the biotech is also developing PARP inhibitors that could have advantages over cancer drugs currently available from this class. The post Eikon Raises $350M for Cancer Drug Pipeline Led by Melanoma Med in Pivotal Testing appeared first on MedCity News.

Leads 253
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

How Digital Patient Intake is Revolutionizing Healthcare

Referral MD

We live in a world of instant communication and on-demand services. Yet, the healthcare experience often begins with a decidedly analog ritual: The dreaded patient intake form. While medical science advances, too many clinics still rely on cumbersome paperwork. For too long, the administrative side of healthcare has lagged behind its clinical advancements.

article thumbnail

Pharma Digital Marketing: Strategies to Boost Engagement and Drive ROI for Pharma Brands

Pharma Marketing Network

Introduction In todays fast-paced world, pharma digital marketing is more than just a strategyit’s a necessity. With increasing competition, strict regulations, and changing consumer behavior, pharmaceutical brands must embrace digital transformation to stay relevant. But how can pharma marketers break through the noise, engage their audience, and see real ROI?

Pharma 52
article thumbnail

The Power of the Rearview: Learning from the Past to Drive Forward

Scott Burrows

In business, leadership, and life, theres a reason the windshield is bigger than the rearview mirroryour focus should always be on where youre going, not just where youve been. But that doesnt mean the past is irrelevant. In fact, the rearview mirror serves a critical purpose: it helps us learn, adjust, and make better decisions moving forward. The key is knowing how to glance back without getting stuck there.

article thumbnail

A Startup Provides Physician-led Virtual Visits for Women at Risk for Heart Disease

MedCity News

Womens cardiovascular risk factors often don’t get the attention they merit until it’s too late. Systole Health CEO and Co-founder talked about how the company addresses this challenge. The post A Startup Provides Physician-led Virtual Visitsfor Women at Risk for Heart Disease appeared first on MedCity News.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Greener method for ethylene oxide manufacture identified

European Pharmaceutical Review

Scientists have developed a new, potentially safer method to produce ethylene oxide. Based on the proposed technique, adding small amounts of nickel atoms to silver catalysts can maintain production efficiency while eliminating the need for chlorine, leading to a reduced environmental impact for ethylene oxide manufacturing. What sparked this development?

article thumbnail

AI-Powered Pharma: How Artificial Intelligence is Transforming Drug Development,

Pharma IQ

Discover how AI is transforming pharmaceutical development, from drug discovery to clinical trials, supply chain resilience, and personalised medicine.

Pharma 130
article thumbnail

Pfizer names Patrizia Cavazzoni, former top FDA official, as chief medical officer

PharmaVoice

Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida Habtezion.

FDA 130
article thumbnail

Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz Segment

MedCity News

Thermo Fisher Scientific agreed to acquire the Purification and Filtration business of 3M spinoff Solventum. Filters and membranes from this business segment are used globally in applications such as biopharmaceutical manufacturing. The post Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz Segment appeared first on MedCity News.

article thumbnail

The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

article thumbnail

Evidence builds behind Regeneron's deafness gene therapy

pharmaphorum

Ten out of 11 children with congenital deafness treated with a gene therapy developed by Regeneron have seen "notable" improvements in hearing

129
129
article thumbnail

Mitazalimab shows promising survival rates in cancer study

PharmaTimes

Updated data from phase 2 study reveals survival benefit

115
115
article thumbnail

Incentivizing rare disease R&D is getting tougher, but revamped policies could turn the tide

PharmaVoice

Orphan drug development has long been incentivized by government policy. But as the financial math shifts, so do the risks of bringing rare disease drugs to market.

article thumbnail

Tia Teams Up with Nourish to Provide Nutrition Support to Women

MedCity News

Through a partnership with Nourish, Tias members will have access to virtual personalized nutrition guidance that can address a range of needs, such as hormonal balance, fertility, chronic disease management and weight management. The post Tia Teams Up with Nourish to Provide Nutrition Support to Women appeared first on MedCity News.

article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

Vaccine sector on edge as HHS cancels flu meeting

pharmaphorum

An FDA advisory committee due to be held in March to discuss the formulation of influenza vaccines for the 2025/26 flu season has been cancelled.

FDA 111
article thumbnail

Semaglutide shortage ends as FDA sets deadline for compounders

Pharmaceutical Technology

With Novo Nordisks blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed for now.

FDA 111
article thumbnail

ICR researchers develop blood test to uncover how childhood tumours adapt

PharmaTimes

It is hoped that the approach will lead to more targeted treatments for childhood cancers

Leads 79